Safety and Efficacy Study of Botulinum Toxin Type A to Treat Lower Urinary Symptoms Due to Benign Prostatic Hyperplasia

NCT00284518 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

380

Enrollment

INDUSTRY

Sponsor class

Conditions

Benign Prostatic Hyperplasia

Interventions

BIOLOGICAL: botulinum toxin Type A
DRUG: normal saline

Sponsor

Allergan